Stay updated on Cobimetinib in Relapsed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Cobimetinib in Relapsed Multiple Myeloma Clinical Trial page.

Latest updates to the Cobimetinib in Relapsed Multiple Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRecord History shows a new revision entry (v3.5.0) added and the previous revision (v3.4.3) removed.SummaryDifference0.1%

- Check22 days agoChange DetectedRevision history updated: added entry for v3.4.3 and removed v3.4.2 from the study record history.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.4.2 added and v3.4.1 removed, with the government funding notice removed; no study data or core functionality is affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check58 days agoChange DetectedAdded a site-wide notice about government funding and the NIH Clinical Center status, and updated the revision from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check65 days agoChange DetectedThe history view now includes a glossary option and shows color-coded change highlights (green for additions, red for deletions) along with the updated revision label (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check79 days agoChange DetectedA new revision entry, Revision: v3.3.4, was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cobimetinib in Relapsed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cobimetinib in Relapsed Multiple Myeloma Clinical Trial page.